Lumayag, Baby Boy N.

HRN: 21-83-89  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2022
AMPICILLIN 250MG (VIAL)
08/02/2022
08/08/2022
IVT
150mg
Q12
Tc Neonatal Pneumonia
Waiting Final Action 
08/02/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
08/02/2022
08/08/2022
IVT
15mg
Q24
Neonatal Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: